Low Graphics
|
Accessibility
|
Site Map
|
Help
|
Text Size:
A
|
A
+
|
A
++
Links
BNF
BNF for Children
SMC
NHS Grampian
CGI
Grampian Medicines Management
Home
GJF Home
eGJF
Medicines Management
Policies
Newsletters
Shared Care Protocols
PGDs
GMM
GJF
Docs
Policies
Newsletters
SCPs
PGD
GMM
Google
You are here:
GMM
>
Home_new
>
Site Map
Home
GJF
Joint Wound Care Formulary
. . . Introduction
1. Gastro-Intestinal System
1.1 Dyspepsia and Gastro-oesophageal reflux disease
1.2 Antispasmodics and other drugs altering gut motility
1.3 Antisecretory drugs and mucosal protectants
1.4 Antidiarrhoeal drugs
1.5 Chronic bowel disorders
1.6 Laxatives
1.7 Local Preparations for anal and rectal disorders
1.9 Drugs affecting intestinal secretions
2. Cardiovascular System
2.1 Positive inotropic drugs
2.2 Diuretics
2.3 Anti-arrhythmic drugs
2.4 Beta-adrenoceptor blocking drugs
2.5 Hypertension and heart failure
2.6 Nitrates, calcium-channel blockers and potassium channel activators
2.6.1 Nitrates
2.6.2 Calcium-channel blockers
2.6.3 Other antianginal drugs
2.6.4 Peripheral Vasodilators
2.7 Sympathomimetics
2.8 Anticoagulants and protamine
2.8.1 Parenteral anticoagulants
2.8.2 Oral anticoagulants
2.8.3 Antidotes to anticoagulants
2.9 Antiplatelet drugs
2.10 Fibrinolytic drugs
2.11 Antifibrinolytic drugs and haemostatics
2.12 Lipid-regulating drugs
Joint Statement - lipid regulating drugs
2.13 Local sclerosants
2.14 Drugs affecting the ductus arteriosus
3. Respiratory System
Administration of drugs to the lungs
3.1 Bronchodilators
3.2 Corticosteroids
3.3 Cromoglicate, related therapy and leukotriene receptor antagonists
3.4 Antihistamines, and the treatment of allergic emergencies
3.4.1 Antihistamines
3.4.2 Allergen Immunotherapy
3.4.3 The treatment of allergic emergencies
3.5 Respiratory stimulants and pulmonary surfactants
3.6 Oxygen
3.7 Mucolytics
3.9 Cough preparations
3.9.1 Cough Suppressants
3.9.2 Expectorant and Demulcent Cough Preparations
4. Central Nervous System
4.1 Hypnotics and anxiolytics
4.1.1 Hypnotics
4.1.2 Anxiolytics
4.2 Drugs used in psychoses and related disorders
4.2.1 Antipsychotic Drugs
4.2.2 Antipsychotic Depot Injections
4.2.3 Antimanic Drugs
4.3 Antidepressants
4.4 CNS stimulants and other drugs used for ADHD
4.5 Drugs used in the treatment of obesity
4.5.1 Anti-Obesity Drugs Acting on the Gastro-Intestinal Tract
4.5.2 Centrally Acting Appetite Suppressants
4.6 Drugs used in nausea and vertigo
4.7 Analgesics
4.7.1 Non-opioid analgesics
4.7.2 Opioid analgesics
4.7.3 Neuropathic pain
4.7.4 Antimigraine drugs
4.7.4.1 Treatment of the Acute Migraine Attack
4.7.4.2 Prophylaxis of Migraine
4.8 Antiepileptics
4.9 Drugs used in parkinsonism and related disorders
4.9.1 Dopaminergic Drugs Used In Parkinsonism
4.9.2 Antimuscarinic Drugs Used In Parkinsonism
4.9.3 Drugs Used In Essential Tremor, Chorea, Tics, And Related Disorders
4.10 Drugs used in substance dependence
4.10.1 Alcohol dependence
4.10.2 Nicotine dependence
4.10.3 Opioid dependence
4.11 Drugs for dementia
5. Infections
Hospital/Acute Care
Paediatric
Empirical guidance
Gentamicin and vancomycin
Adult Hospital Empirical Guidance
GI and abdominal
Cardiovascular
Respiratory
CNS
Urinary tract
Genital system
Blood
Musculoskeletal
Eye
ENT
Skin
IV to oral switch
Primary Care Guidance
Policies and Guidance
News Letter
A to Z
6. Endocrine System
6.1 Drugs used in diabetes
6.1.1 Insulin
6.1.2 Antidiabetic Drugs
6.1.3 Diabetic ketoacidosis
6.1.4 Treatment of hypoglycaemia
6.2 Thyroid and antithyroid drugs
6.2.1 Thyroid Hormones
6.2.2 Antithyroid Drugs
6.3 Corticosteroids
6.3.1 Replacement Therapy
6.3.2 Glucocorticoid Therapy
6.4 Sex hormones
6.4.1 Female Sex Hormones
6.4.1.1 Oestrogens and Hormone Replacement Therapy (HRT)
6.4.1.2 Progestogens
6.4.2 Male Sex Hormones and Antagonists
6.5 Hypothalamic and pituitary hormones and anti-oestrogens
6.6 Drugs affecting bone metabolism
6.7 Other endocrine drugs
7. Obstetrics, Gynaecology and Urinary Tract Disorders
7.1 Drugs used in obstetrics
7.2 Treatment of vaginal and vulval conditions
7.2.1 Preparations for vaginal and vulval changes
7.2.2 Vaginal and vulval infections
7.3 Contraceptives
7.3.1 Combined Hormonal Contraceptives (CHC)
7.3.2 Progestogen-Only Contraceptives
7.3.3 Spermicidal contraceptives
7.3.4 Contraceptive devices
7.3.5 Emergency Contraception
7.4 Drugs for genito-urinary disorders
7.4.1 Drugs for urinary retention
7.4.2 Drugs for urinary frequency, enuresis, and incontinence
7.4.3 Drugs used in urological pain
7.4.4 Bladder Instillations and Urological Surgery
7.4.5 Drugs for Erectile Dysfunction
8. Malignant Disease and Immunosuppresion
8.1 Cytotoxic drugs
8.1.1 Alkylating Drugs
8.1.2 Cytotoxic Antibiotics
8.1.3 Antimetabolites
8.1.4 Vinca Alkaloids and Etoposide
8.1.5 Other Antineoplastic Drugs
8.2 Drugs affecting the immune response
8.2.1 Antiproliferative Immunosuppressants
8.2.2 Corticosteroids and other Immunosuppressants
8.2.3 Anti-lymphocyte monoclonal antibodies
8.2.4 Other Immunomodulating Drugs
8.3 Sex hormones and hormone antagonists in malignant disease
8.3.1 Oestrogens
8.3.2 Progestogens
8.3.4 Hormone Antagonists
8.3.4.1 Breast Cancer
8.3.4.2 Prostate Cancer and Gonadorelin Analogues
8.3.4.3 Somatostatin Analogues
9. Nutrition and Blood
9.1 Anaemias and some other blood disorders
9.1.1 Iron-Deficiency Anaemias
9.1.2 Drugs used in Megaloblastic Anaemias
9.1.3 Drugs used in Hypoplastic, Haemolytic, and Renal Anaemias
9.1.4 Drugs used in platelet disorders
9.1.6 Drugs used in Neutropenia
9.1.7 Drugs used to mobilise stem cells
9.2 Fluids and electrolytes
9.2.1 Oral Preparations for Fluid and Electrolyte Imbalance
9.2.2 Parenteral Preparations for Fluid and Electrolyte Imbalance
9.2.2.1 Electrolytes and Water
9.2.2.2 Plasma and Plasma Substitutes
9.3 Intravenous nutrition
9.4 Oral nutrition
9.4.1 Foods for Special Diets
9.5 Minerals
9.5.1 Calcium and Magnesium
9.5.2 Phosphorus
9.5.2.1 Phosphate Supplements
9.5.2.2 Phosphate-Binding Agents
9.5.4 Zinc
9.6 Vitamins
9.8 Metabolic disorders
10. Musculoskeletal and Joint Disease
10.1 Drugs used in rheumatic diseases and gout
10.1.1 Non-steroidal anti-inflammatory drugs (Nsaids)
10.1.2 Corticosteroids
10.1.2.1 Systemic Corticosteroids
10.1.2.2 Local Corticosteroid Injections
10.1.3 Drugs which suppress the rheumatic disease process
10.1.4 Gout and cytotoxic-induced hyperuricaemia
10.2 Drugs used in neuromuscular disorders
10.2.1 Drugs that enhance neuromuscular transmission
10.2.2 Skeletal muscle relaxants
10.3 Drugs used for the relief of soft-tissue inflammation
10.3.1 Enzymes
10.3.2 Rubefacients and other topical antirheumatics
11. Eye
11.1 Administration of drugs to the eye
11.2 Control of microbial contamination
11.3 Anti-infective eye preparations
11.4 Corticosteroids and other anti-inflammatory preparations
11.5 Mydriatics and cyclopegics
11.6 Treatment of glaucoma
11.7 Local anaesthetics
11.8 Miscellaneous ophthalmic preparations
11.8.1 Tear deficiency, ocular lubricants, and astringents
11.8.2 Ocular diagnostic and peri-operative preparations and photodynamic treatment
Ocular diagnostic and peri-operative preparations
Subfoveal choroidal neovascularisation
12. Ear, Nose and Oropharynx
12.1 Drugs acting on the ear
12.1.1 / 2 Otitis Externa and Otitis Media
12.1.3 Removal of Ear Wax
12.2 Drugs acting on the nose
12.2.1 Drugs used in Nasal Allergy
12.2.2 Topical Nasal Decongestants
12.2.3 Nasal Preparations for Infection and Epistaxis
12.3 Drugs acting on the oropharynx
12.3.1 Drugs for Oral Ulceration and Inflammation
12.3.2 Oropharyngeal Anti-Infective Drugs
12.3.3 Lozenges and Sprays
12.3.4 Mouthwashes, Gargles, and Dentifrices
12.3.5 Treatment of Dry Mouth
13. Skin
13.1 Management of skin conditions
13.2 Emollient and barrier preparations
13.2.1 Emollients
13.2.2 Barrier Preparations
13.3 Topical antipruritics
13.4 Topical corticosteroids
13.5 Preparations for eczema and psoriasis
13.6 Acne and rosacea
13.7 Preparations for warts and calluses
13.8 Sunscreens and camouflagers
13.8.1 Sunscreen Preparations
13.9 Shampoos and other preparations for scalp and hair conditions
13.10 Anti-infective skin preparations
13.10.1 Antibacterial preparations
13.10.2 Antifungal preparations
13.10.3 Antiviral preparations
13.10.4 Parasiticidal preparations
13.11 Skin cleansers and antiseptics
13.12 Antiperspirants
13.13 Topical circulatory preparations
14. Immunological products and vaccines
14.1 Vaccines and guidance
14.3 Storage and use
14.5 Immunoglobulins
15. Anaesthesia
15.1 General anaesthesia
15.1.1 Intravenous Anaesthetics
15.1.2 Inhalational Anaesthetics
15.1.3 Antimuscarinic Drugs
15.1.4 Sedative and Analgesic Peri-Operative Drugs
15.1.5 Muscle Relaxants
15.1.6 Drugs for reversal of neuromuscular blockade
15.1.7 Antagonists for Central and Respiratory Depression
15.1.8 Drugs for Malignant Hyperthermia
15.2 Local anaesthesia
Appendix 1. Drugs for emergency use in General Practice
Appendix 2. Palliative Care
Appendix 3. Oral Nutritional Supplements (ONS)
Appendix 4. Gluten-free and cow's milk protein-free products
Cow's milk protein intolerance
Gluten-free products
Medicines No Longer included in the GJF
Medicines not recommended for use in NHS Grampian
1. Gastro-Intestinal System
2. Cardiovascular System
3. Respiratory System
4. Central Nervous System
5. Infections
6. Endocrine System
7. Obstetrics, Gynaecology and Urinary Tract Disorders
8. Malignant Disease and Immunosuppresion
9. Nutrition and Blood
10. Musculoskeletal and Joint Disease
11. Eye
12. Ear, Nose and Oropharynx
Other Products
SMC Non Submission Statements
eGJF
eGJF for Gpass
eGJF Download
eGJF Feedback
Medicines Management
Grampian Medicines Management Group (GMMG)
Medicine Guidelines and Policies Group (MGPG)
Formulary Group (FG)
Formulary Group Decisions
2013
April
March
February
January
2012
December
November
October
September
August
July
June
May
April
March
February
January
2011
December
November
October
September
August
July
June
May
April
March
February
January
2010
December
November
October
September
August
July
June
May
April
March
February
January
2009
December
November
October
September
August
July
June
May
April
March
February
January
2008
December
November
October
September
August
July
June
May
April
March
February
January
2007
December
November
October
September
August
July
June
May
April
March
February
January
2006
December
November
October
September
August
July
June
May
April
March
February
January
Formulary Group Work Programme
Policies
Prescribing processes guidance
Group request
Non-formulary requests
Non-medical prescribing
Policy & Framework
Resources
Prescribing session
A-Z Local Policies & guidance
Policies in BNF order
News Letters
2013
2012
2011
2010
Guidance notes
Shared Care Protocols
Renal Protocols
Index
Patient Group Directions
